180 related articles for article (PubMed ID: 37561286)
1. Plasma metabolome identifies potential biomarkers of gastric precancerous lesions and gastric cancer risk.
Li B; Shu X; Jiang H; Shi C; Qi L; Zhu L; Zhou J; Tang M; Hu A
Metabolomics; 2023 Aug; 19(8):73. PubMed ID: 37561286
[TBL] [Abstract][Full Text] [Related]
2. Identification and Validation of Plasma Metabolomic Signatures in Precancerous Gastric Lesions That Progress to Cancer.
Huang S; Guo Y; Li ZW; Shui G; Tian H; Li BW; Kadeerhan G; Li ZX; Li X; Zhang Y; Zhou T; You WC; Pan KF; Li WQ
JAMA Netw Open; 2021 Jun; 4(6):e2114186. PubMed ID: 34156450
[TBL] [Abstract][Full Text] [Related]
3. Use of Metabolomics as a Complementary Omic Approach to Implement Risk Criteria for First-Degree Relatives of Gastric Cancer Patients.
Corona G; Cannizzaro R; Miolo G; Caggiari L; De Zorzi M; Repetto O; Steffan A; De Re V
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518896
[TBL] [Abstract][Full Text] [Related]
4. Plasma sample based analysis of gastric cancer progression using targeted metabolomics.
Lario S; Ramírez-Lázaro MJ; Sanjuan-Herráez D; Brunet-Vega A; Pericay C; Gombau L; Junquera F; Quintás G; Calvet X
Sci Rep; 2017 Dec; 7(1):17774. PubMed ID: 29259332
[TBL] [Abstract][Full Text] [Related]
5. Metabolome and microbiome alterations in tongue coating of gastric precancerous lesion patients.
Hao Y; Zhang R; Morris R; Cheng F; Zhu Z; Xu Y; Wang Y
Expert Rev Gastroenterol Hepatol; 2021 Aug; 15(8):949-963. PubMed ID: 33252275
[No Abstract] [Full Text] [Related]
6. Discriminating gastric cancer and gastric ulcer using human plasma amino acid metabolic profile.
Jing F; Hu X; Cao Y; Xu M; Wang Y; Jing Y; Hu X; Gao Y; Zhu Z
IUBMB Life; 2018 Jun; 70(6):553-562. PubMed ID: 29626382
[TBL] [Abstract][Full Text] [Related]
7. Tissue-based metabolomics reveals metabolic signatures and major metabolic pathways of gastric cancer with help of transcriptomic data from TCGA.
Wang Y; Chen W; Li K; Wu G; Zhang W; Ma P; Feng S
Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34549263
[TBL] [Abstract][Full Text] [Related]
8. Metabolomic Analysis of Gastric Cancer Progression within the Correa's Cascade Using Ultraperformance Liquid Chromatography-Mass Spectrometry.
Kuligowski J; Sanjuan-Herráez D; Vázquez-Sánchez MA; Brunet-Vega A; Pericay C; Ramírez-Lázaro MJ; Lario S; Gombau L; Junquera F; Calvet X; Quintás G
J Proteome Res; 2016 Aug; 15(8):2729-38. PubMed ID: 27384260
[TBL] [Abstract][Full Text] [Related]
9. Targeted Metabolomic Profiling of Plasma Samples in Gastric Cancer by Liquid Chromatography-Mass Spectrometry.
Matsumoto T; Fukuzawa M; Itoi T; Sugimoto M; Aizawa Y; Sunamura M; Kawai T; Nemoto D; Shinohara H; Muramatsu T; Suzuki Y; Kagawa Y; Suguro M; Uchida K; Koyama Y; Madarame A; Morise T; Yamaguchi H; Sugimoto A; Yamauchi Y; Kono S; Naito S
Digestion; 2023; 104(2):97-108. PubMed ID: 36404717
[TBL] [Abstract][Full Text] [Related]
10. Serum Metabolic Profiling Analysis of Chronic Gastritis and Gastric Cancer by Untargeted Metabolomics.
Yu L; Lai Q; Feng Q; Li Y; Feng J; Xu B
Front Oncol; 2021; 11():636917. PubMed ID: 33777793
[TBL] [Abstract][Full Text] [Related]
11. Systematic review and meta-analysis: Artificial intelligence for the diagnosis of gastric precancerous lesions and Helicobacter pylori infection.
Dilaghi E; Lahner E; Annibale B; Esposito G
Dig Liver Dis; 2022 Dec; 54(12):1630-1638. PubMed ID: 35382973
[TBL] [Abstract][Full Text] [Related]
12. The gastric mucosal protective effects of astragaloside IV in mnng-induced GPL rats.
Cai T; Zhang C; Zhao Z; Li S; Cai H; Chen X; Cai D; Liu W; Yan Y; Xie K; Pan H; Zeng X
Biomed Pharmacother; 2018 Aug; 104():291-299. PubMed ID: 29775897
[TBL] [Abstract][Full Text] [Related]
13. Metabolomic phenotype of gastric cancer and precancerous stages based on gas chromatography time-of-flight mass spectrometry.
Yu L; Aa J; Xu J; Sun M; Qian S; Cheng L; Yang S; Shi R
J Gastroenterol Hepatol; 2011 Aug; 26(8):1290-7. PubMed ID: 21443661
[TBL] [Abstract][Full Text] [Related]
14. Metabolomic Analysis Using Liquid Chromatography/Mass Spectrometry for Gastric Cancer.
Liang Q; Wang C; Li B
Appl Biochem Biotechnol; 2015 Aug; 176(8):2170-84. PubMed ID: 26088916
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of gastric cancer precursors in gastroscopy-screened adults by family history of gastric cancer and of cancers other than gastric.
Wu R; Yang C; Ji L; Fan ZN; Tao YW; Zhan Q
BMC Cancer; 2020 Nov; 20(1):1110. PubMed ID: 33198658
[TBL] [Abstract][Full Text] [Related]
16. Targeted metabolomic profiles of serum amino acids and acylcarnitines related to gastric cancer.
Li D; Lu Y; Zhao F; Yan L; Yang X; Wei L; Yang X; Yuan X; Yang K
PeerJ; 2022; 10():e14115. PubMed ID: 36221263
[TBL] [Abstract][Full Text] [Related]
17. Serum peptide mapping in gastric precancerous lesion and cancer.
Li P; Ma D; Zhu ST; Tang XD; Zhang ST
J Dig Dis; 2014 May; 15(5):239-45. PubMed ID: 24438315
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive diagnosis and evaluation of curative surgery for gastric cancer by using NMR-based metabolomic profiling.
Jung J; Jung Y; Bang EJ; Cho SI; Jang YJ; Kwak JM; Ryu DH; Park S; Hwang GS
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S736-42. PubMed ID: 25092158
[TBL] [Abstract][Full Text] [Related]
19. Circulating metabolites as potential biomarkers for the early detection and prognosis surveillance of gastrointestinal cancers.
Song G; Wang L; Tang J; Li H; Pang S; Li Y; Liu L; Hu J
Metabolomics; 2023 Apr; 19(4):36. PubMed ID: 37014438
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
